chrisvoncsefalvay/vaers-outcomes huggingface dataset:
my tongue felt furry after 3 hours, i felt itchy and very sore arm plus light headed; my tongue felt furry after 3 hours, i felt itchy and very sore arm plus light headed; my tongue felt furry after 3 hours, i felt itchy and very sore arm plus light headed; my tongue felt furry after 3 hours, i felt itchy and very sore arm plus light headed; This is a spontaneous report from a contactable other HCP. This 56-Years-Old non pregnant female other HCP received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 04Feb2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation (Age at vaccination 56 years). Medical history included, drug hypersensitivity. Concomitant medication(s) included acetaminophen (ACETAMINOPHEN); ubidecarenone (COQ-10); biotin (BIOTIN); angelica archangelica root, beta vulgaris root, betula pendula leaf, centaurea benedicta herb, cimicifuga racemosa root, equisetum arvense, gentiana lutea root, matricaria recutita flower, petroselinum crispum leaf, rumex crispus root, solidago virgaurea herb, taraxacum officinale root (LIVER CLEANSE [ANGELICA ARCHANGELICA ROOT;BETA VULGARIS ROOT;BETULA PENDULA LEAF;CENTAUREA BENEDICTA HERB;CIMICIFUGA RACEMOSA ROOT;EQUISETUM ARVENSE;GENTIANA LUTEA ROOT;MATRICARIA RECUTITA FLOWER;PETROSELINUM CRISPUM LEAF;RUMEX CRISPUS ROOT;SOLIDAGO) super liver cleanse. The patient previously took iodine and experienced drug hypersensitivity, penicillin, adverse reactions to steroids. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. On 04Feb2021 patient experienced my tongue felt furry after 3 hours, i felt itchy and very sore arm plus lightheaded. Therapeutic measures were taken as a result of all events includes took Benadryl (2) 9 days later arm still sore went to see physician and he prescript loratadine 10mg and naproxen 500 mg. The outcome for all events was recovering.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
pt developed uncontrollable diarhea.  Since taking the vax he has not been able to have a normal bowel movement or have a solid stool. He has tried to change his diet but that has not helped.  He reached out to his PCP and was told to try taking probiotics and Metamucil which has not helped.  His surgeon scheduled him for a colonoscopy scheduled for 6/2.  They will take a stool sample at this time.
she had had the Pfizer Vaccine and had a black eye too; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported), via an unspecified route on an unspecified date as dose number unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced black eye. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
17cmx10cm area of redness, warmth and induration. Treated at urgent care with cephalexin.
Vomiting, generalized c/o not feeling well, temp 99.9.  Tylenol 325mg prn.
(R) thigh 0.5 cm in diameter red raised nodule (L) thigh 0.25 cm in diameter red raised nodule
This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY, NASOPHARYNGITIS, DIZZINESS, TENDERNESS, and LYMPHOEDEMA in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Nov-2021, the patient experienced PAIN IN EXTREMITY, NASOPHARYNGITIS, and DIZZINESS. On 04-Nov-2021, the patient experienced TENDERNESS and LYMPHOEDEMA. At the time of the report, PAIN IN EXTREMITY, NASOPHARYNGITIS, DIZZINESS, TENDERNESS, and LYMPHOEDEMA outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and Treatment medications were not provided   This case was linked to MOD-2021-377121, MOD-2021-377089 (Patient Link).
Pt has a history of AML and is undergoing chemotherapy.  Pt had a fever and chills for 3 days and was admitted for positive blood cultures and also found to be COVID positive.
Large redness area on right thigh where DTaP was given, mild tenderness, warm to touch, hard knot underneath.
Redness, swelling, irritation at injection site. Worsened over 3 days. Used hydrocortisone to reduce swelling. Helped relieve symptoms but not fully subsided.
Chest tightness/muscle pain near left ribs just under breast. Felt when taking very deep breaths or coughing.  I have not been sick with a cough recently, however it feels similar to a time in the past when I possibly pulled a muscle due to coughing.
This case was reported by a nurse, via a sales representative, and described the occurrence of not responding to therapy in a subject of unspecified age and gender who was vaccinated with hepatitis A inactivated and hepatitis B recombinant vaccine (Twinrix, GlaxoSmithKline) for prophylaxis.  Concurrent medical conditions included HIV positive.  On unspecified dates, the subject received 3rd dose, 2nd dose and 1st dose of Twinrix, ("adult dose", unknown).  At an unspecified time after vaccination with 3 dose series of Twinrix, the subject experienced not responding to therapy.  The unspecified titers were possibly being drawn at six months.  The nurse reported that "several of their HIV positive patients did not respond to the 3 dose series of Twinrix", but did not provide a specific number of patients.  At the time of reporting the outcome of the event was unspecified.  The nurse considered the event was probably related to vaccination with Twinrix.
Information has been received from a physician concerning a 69 year old female pt, who was well at the time of vaccination, with no history of allergies and with diabetes who on 1/13/03 was vaccinated IM in the left deltoid with a first dose of pneumococcal vaccine 23 polyvalent (644219/1079M). Concomitant medications are medications for diabetes, but the names of the medications were not reported. On 1/13/03, within 10-12 hrs following the vaccination, the pt developed erythema distal to the injection site on the left deltoid. The pt had also developed a sore arm. Medical attention was sought. Subsequently the pt was hospitalized and on admission to the hospital it was noted that the pt had a fever and a white blood cell count of 12.2 (units and normal values not reported). The physician noted that the pt had an elevated white blood cell count. Blood cultures were done, but results are unknown. The pt was treated with IV Unasyn and the pt had recovered by 1/21/03. The physician would like an investigation into this particular lot. The physician also reported that a male pt was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (644219/1079M) and had a very sore arm (WAES0301USA01695). Additional info has been requested.
c/o severe pain at site of injection and above into the shoulder area with limited range of motion.   had pcp examine arm and has been rx'd pain medication.
Upon vaccination patient seemed to be startled for a quick moment.  As I prepared the paperwork for the second shot patient asked to hold off as she was having difficulty with visual disturbances.  She began to sweat and color left her face ( she became pale).  I fanned patient , gave her water and candy just in case she was either dehydrated or sugar was low.  Patient took the items and I continued to engage patient  in conversation.  She answered the questions accurately but seemed unaware of certain moments that took place.  She was having difficulty with her vision, and had a moment where her eyes moved in an abnormal fashion.  Patient seemed to be having an absence seizures due to her brief, sudden lapses of consciousness.  911 and EMS were contacted and arrived they took her blood pressure which seemed to be in the range of 88/59.  When speaking with patient she seemed to have had a similar occurrence in college.  Parents came at patients request and they also stated that she has had at least 3 occurrences of this.  I suggested follow up with a neurologist and EMS advised her that she should go to the hospital.  I followed up the next day and patient had made appointments with cardiologist nd neurologist.
bruising more easily; increase in joint pain; This is a spontaneous report from a contactable other HCP. A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced bruising more easily during the past few months; md not aware. Patient is worried about the side effects of therapy, especially the risk for blood clots. Patient noticed in increase in joint pain, MD aware. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Rash on lower extremity rash (waste to ankle); This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of RASH (Rash on lower extremity rash (waste to ankle)) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic kidney disease and Rheumatoid arthritis.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced RASH (Rash on lower extremity rash (waste to ankle)). On 12-Feb-2021, RASH (Rash on lower extremity rash (waste to ankle)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Cream lotion.  Stopped Methotrexate at providers request before vaccine.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
pt had brief sz w/fever approx 1 hr p/vax; pt was taken to ER but was fine there & not seen by MD; pt had a 2nd brief sz w/t102 @ MN;
Two months after the second shot i had debilitating joint pain in both shoulders   also felt like radiated down my arms   also many other joints affected     at the end of two months almost to the day the pain and limited mobility seemed  to subside.  don't want to go thru that again
Within 1 minute of immunization he had onset of erythematous rash on L thigh. Over the next x2 days rash spread to head, neck, arms, & trunk. He had audible wheezing. No respiratory distress, angioedema, anaphylaxis. He is now x6 days from immunization and is completely resolved. Did not have similar reaction to previous HepB or Rotavirus.
Today 11/29/12 - mother reported that client had a severe rxn 2 days after Td & polio shots - Rxn was hives & she required a steroid.
Information has been received from a consumer concerning her child who was vaccinated with a dose of hepatitis B virus vaccine. Concomitant therapy included a dose of diphtheria toxoid (+) pertussis acellular vaccine (+) tetanus toxoid. Subsequently, the patient experienced infantile spasms. It was unknown if medical attention was sought. No product quality complaint was involved. Upon internal review, infantile spasms was considered an other important medical event (OMIC). Additional information has been requested. 06/09/2005:  Recovery status unknown.
pt recvd vax & exp h/a, dizziness, joint pains, muscle aches, local reaction characterized by redness, pain swelling, warmth & itching also fever, lymphadenopathy;
This case was reported by a nurse via call center representative and described the occurrence of pain in arm in an unspecified number of patients who received SHINGRIX. On an unknown date, the patient received SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced pain in arm, swelling arm and erythema of extremities. On an unknown date, the outcome of the pain in arm, swelling arm and erythema of extremities were unknown. It was unknown if the reporter considered the pain in arm, swelling arm and erythema of extremities to be related to SHINGRIX. Additional details were provided as follows: This case was not previously reported to anyone. The age at vaccination was not reported. The patients experienced pain in arm, redness and swelling on arm. The nurse reported that she had noticed this with other patients she had given SHINGRIX to. There were no other identifiers for these patients. This case been linked with US2017196862, reported by the same reporter.
m.d. rpt that after 1st dose of vax pt exp a high fever of 103 to 104.  pt sought unspecified medical attention.
Neck got incredibly stiff, got extremely dizzy and had a severe nausea.   They observed me for over an hour, prescribed Zofran, and told me to go home and rest. My eyes started getting itchy that afternoon. Over the next few days I tried ice packs and warm compress. By Tuesday it was so bad I went to the er. They numbed them and sent me home with a referral to an optometrist if it got worse. I woke up in so much pain I called them crying on Wednesday.  They referred me to my normal optometrist, whom I had seen early March and he diagnosed me with two ulcers in my left corena.
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown demographics. On an unknown dates (time frame: 21-DEC-2015 to 05-JAN-2016), the patients were vaccinated with improperly stored doses of Oral, ROTATEQ lot # L013203, expiry: 28-JAN-2017. No previous temperature excursion reported. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
patient felt faint 5 min after injections, blackedout for approx 10 sec then came to as if nothing happened
Patient was brought in on 03/03/2010 by mother due to generalized rash.
R upper arm significant edema, redness, heat, mild pain + itching R lateral neck moderate redness + edema.
Persistent right shoulder pain (site of injection) associated with pain on extension and abduction present for the last two weeks and starting two days after influenza vaccine. No erythema, warmth, or edema.
Patient started experiencing vomiting, diarrhea, chills and facial soreness. She had a fever of 101 degrees F and symptoms persisted for about 36 hours.
Tingling in hands and legs; Urge to swallow but feel like I won't be able to; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration on 15Mar2021 at 15:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin calcium (ROSUVASTATIN), ramipril (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN); all for unknown indication from an unknown date and unknown if ongoing. On 15Mar2021 at 15:15, the patient experienced tingling in hands and legs and urge to swallow but felt like won't be able to. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling in hands and legs and urge to swallow but feel like won't be able to was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Currently 31 weeks pregnant, estimated delivery Aug 5 Chills, fever, vomiting, joint pain,  nausea, headache, dizziness, syncope Resolved at 12:30 on 6/3
Water breaking day of shot with no contractions until castor oil at 36 hour mark; Pregnancy at time of Vaccination: Yes; first dose on 16Apr2021, second dose on 30Apr2021; first dose on 16Apr2021, second dose on 30Apr2021; This is a spontaneous report received from a contactable healthcare professional (patient). A 35-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in right arm on 30Apr2021 08:45 (Batch/Lot Number: EW0164) as single dose for COVID-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing , seasonal allergy from an unknown date and unknown if ongoing. She received the first dose of BNT162b2 (lot number: ER8729) on 16Apr2021. Concomitant medication(s) included levoglutamide, polaprezinc (ENDOZIN) taken for an unspecified indication, start and stop date were not reported; urtica dioica leaf (NETTLE LEAF) taken for an unspecified indication, start and stop date were not reported; and  "designs for health prenatal pro p". No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was pregnant at time of vaccination. The date of last menstrual period was 03Aug2020, due date was 09May2021. Gestation period was 38 weeks at the time of the second dose of the vaccine. The patient experienced water breaking day of shot (on 30Apr2021 19:15) with no contractions until castor oil at 36 hour mark. The outcome was reported as recovering.; Sender's Comments: Based on the information currently available,The casual association between the reported events and suspected vaccine BNT162B2 cannot be completely excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Initial report received from a healthcare professional on 29 July 2013. A 33-year-old female patient had received first intramuscular dose of ADACEL (Lot number U4586AA, anatomical site of vaccination was not reported) on 29 July 2013. The patient was pregnant at the time of vaccination. The patient's last menstrual period date was 14 January 2013 and the estimated date of delivery was 21 October 2013. The patient's health during pregnancy, risk factors (e.g.: alcohol, tobacco or recreational drugs), medical history, concomitant medications and laboratory tests were not reported. At the time of this report, the patient did not experience any adverse event. List of documents held by the sender: None.
About 3 hours after my shot in my left arm, my  right arm started hurting. As the night progressed, the pain in my right arm got worse. By  morning my hands, wrists, elbows, shoulders and hips were hurting. I met with my PCP on sept 1 and she ordered labs
Severe pain in shoulder surrounding vaccinated area.  Achy, cramping pain.  Severe headache within 90 minutes of vaccine.  Limited range of motion within a few more hours. 4 days later and I still have severe pain in my shoulder.  Almost feels like tendonitis but it isn't related to any tendon. Still having similar headaches every day as well.
NO ADVERSE REACTION REPORTED. MONOVALENT ADMINISTERED INCORRECTLY AS BOOSTER DOSE
05/29/2022, The day after she received her booster shot, she woke up with a mild headache, fever and chills, she then proceeded to throw up clear yellow liquid. We contacted the doctor over a telehealth visit and was recommended to give her some ibuprofen and monitor her and keep her hydrated. By the evening on the same day her symptoms had improved dramatically. She did have some tenderness in her armpit and did not have her fever or nausea the next day.
Patient received the Pfizer COVID-19 vaccine on 1/20/21 and 2/10/21 so was fully vaccinated when they tested positive for COVID-19 on 8/31/21.
Taste of something, dizziness, and headache post vaccine. Did NOT take BP meds this morning. Refused EMS. Systolic 180
Right thigh celllulitis within 24 hrs of injection, resulting in oral and IM IV antibiotics
This spontaneous report was received from a physician via a Company representative concerning to an unspecified patients of unknown age and gender. Medical history and concurrent conditions were not provided. On 25-NOV-2015, the patients were vaccinated with an improperly stored doses of RECOMBIVAX HB lot # K020336(dose, route and the expiration date were not reported). The total cumulative hours out of range were 24 hours with 34 C as the the lowest recorded temperature. The storage type was a refrigerator. There was no concomitant medication provided nor no Product Quality Complaint(PQC) involved. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
1138 - throat swelling, 1143 - chest tightness, 1151 - dyspnea, 1256 - itching, L knee arthralgia, 1404 - head felt like it was going to explode, bilat knees, elbows, and wrists arthralgias, 1614 - felt like I wanted to crawl out of my skin  Went to clinic.  Given neb treatment of albuterol.  Given rx of prednisone starting at 40 mg and tapering which pharmacy refused to fill because after waiting an inordinate amount of time in line, there was "only 10 minutes until closing time."
Patient states she was tired and week for about a week. She missed one day of work as well. She did recover.
Discomfort on the right arm; fever; chill; This is a spontaneous report reported by a consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported, via an unspecified route of administration, on 16Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she had first shot 16Mar and was scheduled to take second shot on 08Apr. On an unspecified date, the patient experienced discomfort on the right arm. She was also experiencing fever and chill. The patient wanted to know if she needed to take second shot. Outcome of the event was not recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.